Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2026-01-21 @ 2:26 PM
Study NCT ID:
NCT02230566
Status:
COMPLETED
Last Update Posted:
2020-07-30
First Post:
2014-08-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3 Study of UX003 Recombinant Human Betaglucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7)
Sponsor:
Ultragenyx Pharmaceutical Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12
Start Date Type:
None
Primary Completion Date:
2016-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-22
First Submit QC Date:
None
Study First Post Date:
2014-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-11-29
Results First Submit QC Date:
None
Results First Post Date:
2018-02-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-05-10
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-07-16
Last Update Post Date:
2020-07-30
Last Update Post Date Type:
ACTUAL